Td Asset Management Inc Prelude Therapeutics Inc Transaction History
Td Asset Management Inc
- $106 Billion
- Q4 2024
A detailed history of Td Asset Management Inc transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Td Asset Management Inc holds 160,652 shares of PRLD stock, worth $144,586. This represents 0.0% of its overall portfolio holdings.
Number of Shares
160,652
Previous 160,652
-0.0%
Holding current value
$144,586
Previous $332,000
38.55%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PRLD
# of Institutions
59Shares Held
30.4MCall Options Held
6.4KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA10.9MShares$9.82 Million0.38% of portfolio
-
Baker Bros. Advisors LP New York, NY10.1MShares$9.11 Million0.14% of portfolio
-
Black Rock Inc. New York, NY1.07MShares$962,0240.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.03MShares$926,2790.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.01MShares$909,3520.0% of portfolio
About Prelude Therapeutics Inc
- Ticker PRLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,369,200
- Market Cap $32.7M
- Description
- Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...